Fibcare® shows correlation with fibrinogen levels by the Clauss method during cardiopulmonary bypass

1 Westaby S. Anti-fibrinolytic therapy in thoracic aortic surgery. Ann Thorac Surg. 1999;67(6):1983–1985;

discussion 1997–1998. doi:10.1016/s0003-4975(99)00354-9.

2 Nomura F, Tamura K, Yoshitatsu M, Katayama A, Katayama K, Ihara K. Changes in coagulation

condition, cytokine, adhesion molecule after repair of type A aortic dissection. Eur J Cardiothorac Surg.

2004;26(2):348–350. doi:10.1016/j.ejcts.2004.05.001.

3 DeAndrade D, Waters JH, Triulzi DJ, et al. Very low rate of patient-related adverse events associated with

the use of intraoperative cell salvage. Transfusion. 2016;56(11):2768–2772. doi:10.1111/trf.13791.

4 Mazzeffi MA, Chriss E, Davis K, et al. Optimal plasma transfusion in patients undergoing cardiac operations

with massive transfusion. Ann Thorac Surg. 2017;104(1):153–160. doi:10.1016/j.athoracsur.2016.09.071.

5 Innerhofer P, Kienast J. Principles of perioperative coagulopathy. Best Pract Res Clin Anaesthesiol.

2010;24(1):1–14. doi:10.1016/j.bpa.2009.09.006.

6 Ranucci M, Baryshnikova E, Crapelli GB, et al. Randomized, double-blinded, placebo-controlled trial of

Nagoya J. Med. Sci. 85. 310–318, 2023

317

doi:10.18999/nagjms.85.2.310

Akihiro Yamada et al

7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc. 2015;4(6):e002066.

doi:10.1161/JAHA.115.002066.

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M. Fibrinogen concentrate reduces intraoperative

bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a

randomized, placebo-controlled trial. J Thorac Cardiovasc Surg. 2013;145(3 Suppl):S178–S185. doi:10.1016/j.

jtcvs.2012.12.083.

Karkouti K, Callum J, Crowther MA, et al. The relationship between fibrinogen levels after cardiopulmonary

bypass and large volume red cell transfusion in cardiac surgery: an observational study. Anesth Analg.

2013;117(1):14–22. doi:10.1213/ANE.0b013e318292efa4.

Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1

vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA.

2015;313(5):471–482. doi:10.1001/jama.2015.12.

Karkouti K, Callum J, Wijeysundera DN, et al. Point-of-care hemostatic testing in cardiac surgery: A

stepped-wedge clustered randomized controlled trial. Circulation. 2016;134(16):1152–1162. doi:10.1161/

CIRCULATIONAHA.116.023956.

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, et al. Efficacy and safety of fibrinogen concentrate in surgical patients: A meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth.

2016;30(5):1196–1204. doi:10.1053/j.jvca.2016.04.015.

Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry

(ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane

Database Syst Rev. 2016;2016(8):CD007871. doi:10.1002/14651858.CD007871.pub3.

Solomon C, Cadamuro J, Ziegler B, et al. A comparison of fibrinogen measurement methods with fibrin

clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in

cardiac surgery patients. Transfusion. 2011;51(8):1695–1706. doi:10.1111/j.1537-2995.2011.03066.x.

Tamura T, Imaizumi T, Kubo Y, Waters JH, Nishiwaki K. Prompt prediction of fibrinogen concentration

during cardiopulmonary bypass: a pilot study. Nagoya J Med Sci. 2020;82(4):623–630. doi:10.18999/

nagjms.82.4.623.

Okahara S, Handoh T, Wakita M, et al. Fibrinogen measurement by a novel point-of-care device with

whole blood: comparison of values against Clauss method. J Anesth. 2021;35(5):757–760. doi: 10.1007/

s00540-021-02987-9.

Imai K, Kotani T, Nakano T, Ushida T, Kikkawa F. Clinical utility and limitations of FibCare® for the

rapid measurement of fibrinogen concentrations: the first clinical experience. Taiwan J Obstet Gynecol.

2018;57(6):899–900. doi:10.1016/j.tjog.2018.10.024.

Yan TD, Bannon PG, Bavaria J, et al. Consensus on hypothermia in aortic arch surgery. Ann Cardiothorac

Surg. 2013;2(2):163–168. doi:10.3978/j.issn.2225-319X.2013.03.03.

Task Force on Patient Blood Management for Adult Cardiac Surgery of the European Association for CardioThoracic Surgery (EACTS) and the European Association of Cardiothoracic Anaesthesiology (EACTA); Boer

C, Meesters MI, Milojevic M, et al. 2017 EACTS/EACTA Guidelines on patient blood management for

adult cardiac surgery. J Cardiothorac Vasc Anesth. 2018;32(1):88–120. doi:10.1053/j.jvca.2017.06.026.

Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding:

guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol.

2017;34(6):332–395. doi:10.1097/EJA.0000000000000630.

Klein AA, Arnold P, Bingham RM, et al. AAGBI guidelines: The use of blood components and their

alternatives 2016. Anaesthesia. 2016;71(7):829–842. doi:10.1111/anae.13489.

Hunt BJ, Allard S, Keeling D, et al. A practical guideline for the haematological management of major

haemorrhage. Br J Haematol. 2015;170(6):788–803. doi:10.1111/bjh.13580.

Ogawa S, Tanaka KA, Nakajima Y, et al. Fibrinogen measurements in plasma and whole blood: a performance evaluation study of the dry-hematology system. Anesth Analg. 2015;120(1):18–25. doi:10.1213/

ANE.0000000000000448.

Solomon C, Baryshnikova E, Tripodi A, et al. Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: analysis of repeatability and agreement of Clauss method within and between six different

laboratories. Thromb Haemost. 2014;112(1):109–117. doi:10.1160/TH13-12-0997.

References End

Nagoya J. Med. Sci. 85. 310–318, 2023

318

doi:10.18999/nagjms.85.2.310

...